We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about coronavirus (COVID-19) treatments available outside of hospital, including information on free prescriptions and lateral flow tests.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
This is a Systematic Review and Meta-Analysis
Collection of documents relating to COVID-19 treatments.
Section (4A.01 - 4A.31) last updated October 2023.
Read about talking therapies and counselling for mental health problems.
MDR-TB is a rising global threat to public health and efforts for its treatment are diluted if the outcomes are not successful
DHSC publications relating to COVID-19 treatments and clinical trials.
The DHSC-led COVID-19 Antivirals and Therapeutics Taskforce co-ordinates the end-to-end provision of treatments for coronavirus (COVID-19) in the UK so that patients get access to safe and effective treatments as soon as possible.
The CMA acts to help NHS patients access combination therapies used to treat serious medical conditions.
First published during the 2022 to 2024 Sunak Conservative government
Topical steroid products are safe and highly effective treatments for the management of a wide range of inflammatory skin diseases but have important risks, especially with prolonged use at high potency. In the coming months, as a result of regulatory...
A document for patients explaining how the highest risk patient groups eligible for new coronavirus treatments will be identified.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).